![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Cmed has announced it will present its encapsia® clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017.
Attendees at both conferences will have the opportunity to learn about how encapsia® streamlines the capture, management and reporting of clinical data, helping trial sponsors to build more agile and flexible trial programs, while improving the accuracy of data and time-to-market for new drugs.
Mobile in Clinical Trials takes place on September 6, 2017 at the Marriott Copley Place, Boston. During the conference, David Connelly, Chief Executive Officer at Cmed, will demonstrate encapsia® in the Technology Showcase between 12.15-12.45pm. He will highlight how the solution is shaping new methodologies for better data collection and visualization in today’s clinical trials, empowering timely decision-making and corrective actions in real-time.
Connelly will then present at DPharm: Disruptive Innovations to Advance Clinical Trials, also being held at the Marriott Copley Place on September 7-8, 2017. Taking place during the ‘Innovative Sources and Solutions’ track at 4.10pm on day one, the presentation is titled “What is immediate clinical data, and what could it mean?” He will discuss how immediate access to clinical trial data with encapsia®, captured and consolidated from a variety of sources, and actionable live ongoing analysis makes all aspects of data review and monitoring easier, improving data quality and both internal and external patient safety monitoring.
“We combine the practical experience of a full service CRO with the latest technology knowhow to inspire and drive real progress throughout the clinical trial process, and ultimately, achieve higher quality outcomes and efficiencies for today’s studies,” said Connelly. “We are delighted to be able to share our vision with delegates at both industry-leading events and provide first-hand insight into how our solutions can achieve greater, speedier and more accurate results.”
During DPharm, sponsors who are looking to leverage new technologies in their clinical trials are invited to visit Cmed at booth #32, where the company will be hosting live demonstrations of its encapsia® clinical data suite.
About Cmed
Cmed is an innovative, full service technology-led CRO. Cmed brings together experienced people and technology, providing customers with a friendly, proactive service, and delivers this service using advanced clinical data capture, management and reporting software and processes. Cmed’s new generation clinical data suite, encapsia™, streamlines the capture, management and reporting of clinical data, saving customers time and money.
Clinical data can be captured flexibly by eSource, multi-media and web eDC, while being displayed in live visual insights, providing live analytics, and allowing within suite audit trailed actions. It is fully compliant with regulatory guidelines, and allows integration with existing systems.
